Science 37® and physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices
February 03 2022 - 7:55AM
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial
Operating System™, and physIQ Inc, a leader in digital medicine,
today announced a collaboration to help research sponsors use
remote biosensors and machine learning to build more robust data
sets. This will help increase the number of digital biomarkers and
generate insights from continuous data streams to more quickly and
objectively demonstrate the safety and efficacy of treatments.
“Strengthening our centralized network of data and devices helps
fuel our unified technology platform and overall Operating System –
enabling us to more effectively deliver today’s more agile clinical
trials,” said Elisa Cascade, Chief Product Officer of Science 37.
“Partnering with physIQ enhances our OS and empowers us to better
identify the specific signals within data collected from biosensors
and other connected devices to provide sponsor with more predictive
biomarkers.”
physIQ’s robust platform scalability, near real-time
capabilities, established FDA clearance, and proven ability to
support large global clinical trials strengthen Science 37’s
ability to support additional novel digital biomarkers, advance
clinical events detection and provide more proactive safety
monitoring. physIQ enables Sponsors to efficiently identify
valuable digital measures from large amount of noise inherent in
biosensors.
“With nearly 1,500 wearables studies in 2020, biosensors and
digital endpoints are becoming a standard component of clinical
trials,” said Gary Conkright, Chief Executive Officer at physIQ.
“Continuous biosensor data is unique and requires specialized
digital infrastructure to operate at scale. We are thrilled to
partner with Science 37 to deliver on the potential of faster,
better clinical trials. Together, physIQ and Science 37 will
provide clinical trial sponsors with faster access to real-world
evidence to better evaluate and quantify the safety and efficacy of
their products.”
About Science 37Science 37 Holdings, Inc.’s
(Nasdaq: SNCE) mission is to enable universal access to clinical
research—making it easier for patients and providers to participate
from anywhere and helping to accelerate the development of
treatments that impact patient lives. As a pioneer of decentralized
clinical trials, the Science 37 Agile Clinical Trial Operating
System (OS) supports today’s more agile clinical research designs
with its full stack, end-to-end technology platform and centralized
networks of patient communities, telemedicine investigators, mobile
nurses, remote coordinators, provider communities, and data and
devices. Configurable to enable almost any study type, the Science
37 OS enables up to 15x faster enrollment, 28% better retention and
3x more diverse patient population with industry-leading workflow
orchestration, evidence generation and data harmonization. For more
information, visit https://www.science37.com.
About physIQphysIQ is the leader in digital
medicine, dedicated to generating unprecedented health insight
using continuous wearable biosensor data and advanced analytics.
Its industry-leading, enterprise-ready cloud platform continuously
collects and processes data from validated wearable biosensors
using a deep portfolio of FDA-cleared analytics. The company has
published one of the most rigorous clinical studies to date in
digital medicine and are pioneers in developing, validating, and
achieving regulatory approval of Artificial Intelligence-based
analytics. With applications in both clinical trial support and
healthcare, physIQ is transforming continuous physiological data
into insight for health systems, payers, and pharmaceutical
companies. For more information, please visit www.physIQ.com.
Follow us on Twitter and LinkedIn.
MEDIA INQUIRIES
Margie KoomanScience 37Phone: (984)
377-3737Email: pr@science37.com
INVESTOR RELATIONS:Caroline
PaulGilmartinInvestors@science37.com
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jul 2023 to Jul 2024